ASK REDCHAT ANYTHING ABOUT CARTESIAN THERAPEUTICS INC.
Cartesian Therapeutics Inc. (NASDAQ: RNAC)
Listen to this Section
$5.87
-0.6850
(
-10.50% )
182.9K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Descartes-08DetailsMyasthenia gravis |
Phase 2b |
| Descartes-08DetailsSystemic lupus erythematosus |
Phase 2 |
| SEL-302 (MMA-101 + ImmTOR)DetailsGenetic disorder, Methylmalonic acidemia |
Phase 1/2 |
| Descartes-15DetailsMultiple myeloma |
Phase 1 |
Market Data
|
| Open |
$5.87 |
| Previous Close |
$6.55 |
| Volume |
182.9K |
| Market Cap |
$184.08M |
| Day Range |
$5.86 - $6.82 |
| 52 Week Range |
$5.60 - $15.57 |
| Shares Outstanding |
29.38M |
| Change % |
-10.50% |
| Net Change |
▼ -0.6850 |
| Insider Ownership |
-0.29% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2016 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-17,401,469.49
| Date |
Type |
Amount Purchased |
Purchaser |
| 2025-04-11 |
Buy |
7342.00 |
SPRINGER TIMOTHY A |
| 2025-01-15 |
Buy |
7962.00 |
SPRINGER TIMOTHY A |
| 2024-12-23 |
Buy |
11303.00 |
SPRINGER TIMOTHY A |
| 2024-11-18 |
Buy |
74157.00 |
SPRINGER TIMOTHY A |
| 2024-10-04 |
Buy |
1801314.00 |
SPRINGER TIMOTHY A |
| 2024-08-14 |
Buy |
7500.00 |
BARABE TIMOTHY C |
| 2024-08-14 |
Buy |
8016.00 |
SPRINGER TIMOTHY A |
| 2024-07-05 |
Sale |
-1636832.00 |
SPRINGER TIMOTHY A |
| 2024-07-03 |
Sale |
-5933.00 |
Malik Kemal |
| 2024-04-10 |
Sale |
-123925.41 |
SPRINGER TIMOTHY A |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
12 |
Jun 16, 2025 |